What question did this study set out to answer?

Investigate how YTHDF1 and TFRC m6A methylation regulate iron metabolism in hypopharyngeal squamous cell carcinoma (HPSCC).

January 1, 2020TheranosticsOpen Access

YTHDF1-enhanced iron metabolism depends on TFRC m⁶A methylation

View Full Paper

Ask AI

Bookmark

Authors

Experimental study demonstrates YTHDF1-driven iron metabolism via TFRC m6A methylation in HPSCC, suggesting a potential therapeutic target.

Investigate how YTHDF1 and TFRC m6A methylation regulate iron metabolism in hypopharyngeal squamous cell carcinoma (HPSCC).
Examined the molecular interaction between YTHDF1 and m6A-modified TFRC transcripts.
Evaluated the impact of targeting YTHDF1 and TFRC-mediated iron metabolism in HPSCC disease models.
YTHDF1 enhanced iron metabolism via an m6A methylation-dependent pathway involving TFRC.
Inhibition of YTHDF1- and TFRC-mediated iron uptake presents a viable therapeutic strategy against HPSCC.

Ye et al. (2020) studied this question.

View Full Paper

Ask AI

Bookmark

Experimental study demonstrates YTHDF1-driven iron metabolism via TFRC m6A methylation in HPSCC, suggesting a potential therapeutic target.